Allscripts Healthcare Solutions Stock News

AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee and regulatory approvals.

Masimo's (MASI) SpHb is likely to enhance perioperative transfusion management and post-operative patient outcomes on pediatric patients.

Does AllScripts Healthcare (MDRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.

Here is how Lantheus Holdings (LNTH) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and strategic deals.

HealthEquity (HQY) witnesses solid growth in HSAs, along with recording robust Custodial and Interchange revenues, in the fourth quarter of fiscal 2022.

EDOC: Healthcare Technology Needs Time To Reach Its Potential

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.

Catalent's (CTLT) latest facility transformation is likely to significantly enhance the global Biologics business.

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.